4.7 Article

Recovery of the T-cell repertoire in CIDP by IV immunoglobulins

期刊

NEUROLOGY
卷 80, 期 3, 页码 296-303

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31827debad

关键词

-

资金

  1. Research Commission of the Heinrich-Heine-University
  2. ECTRIMS (European Conference on Research and Treatment of MS)
  3. Fritz-Thyssen Foundation
  4. Bayer Schering
  5. Biogen Idec
  6. Merck Serono
  7. Teva Neuroscience

向作者/读者索取更多资源

Objective: To investigate changes in the T-cell repertoire in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) without and with treatment of IV immunoglobulins (IVIg). Methods: The T-cell receptor (TCR) repertoire of CD4+ and CD8+ T cells in the peripheral blood was analyzed using CDR3 spectratyping. Patients with CIDP were included without (n = 14) and with IVIg treatment (n = 11) cross-sectionally and longitudinally (n = 2). Results: While the TCR length distribution of patients with CIDP was only moderately altered for most of the V beta elements of CD4+ T cells, the CD8+ population displayed extensive oligoclonal expansions in all analyzed 24 V beta elements. A public expansion of a distinct TCR length in one V beta element within a majority of affected patients was not detectable. Treatment with IVIg reduced the oligoclonal expansions within both the CD4+ and CD8+ population. Conclusions: Our data demonstrate that cytotoxic CD8+ T cells exhibit a much broader activation than CD4+ T cells, indicating a potentially crucial role of CD8+ T cells in the immunopathogenesis of CIDP. The profound oligoclonal response in T-cell activation suggests that multiple peptides may induce and propagate this autoimmune-driven disease. The observed reduction of highly activated T cells may contribute to the therapeutic effects of IVIg. Neurology (R) 2013;80:296-303

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据